Abstract:The production of micro- and nanosized dry powder formulations of pharmaceutical drugs by spraying methods with high yields and desired rheological characteristics is typically challenging from laboratory up to commercial scales. In this work, supercritical CO 2 was used in a supercritical enhanced atomization (SEA) process as a bottom-up method to create micro- and nanoparticles, with an enhanced control over their physicochemical properties, to produce injectable aqueous suspensions of itraconazole (ITZ). The existing drying chamber design was optimized to significantly improve the SEA process product yield. Additionally, a novel set-up was integrated for the continuous production of ITZ particles directly collected in an aqueous stabilizer media by the supercritical enhanced atomization-induced particle entrapment into suspension (SEA-PES) process. To evaluate the influence of various SEA-PES processing parameters on the particle size, morphology, residual solvent, and particle collection yield of each experimental run utilising the in-house built continuous set-up, a solvent screening study followed by a design of experiments (DoE) was carried out. Based on the given output parameters, tetrahydrofuran (THF) was selected as the optimum solvent for ITZ. The best excipient/s for stabilising ITZ micro- and nanoparticles in suspension, respectively, have previously been discovered to be vitamin E TPGS (0.5% w/w) in combination with PVP K30 (0.5% w/w). Using both the SEA and SEA-PES methods, homogeneous ITZ micro- and nanosuspensions (solid content of 200 mg/g) with D50 0.23 ± 0.06 μm and 3.5 ± 0.2 μm were produced, respectively. These suspensions were stable and resuspendable after 365 days of storage at 25 °C. Finally, utilising a newly developed discriminatory dissolution method, the in vitro release characteristics of ITZ micro- and nanosuspensions were evaluated. There was no significant difference between the SEA and SEA-PES methods to generate the drug micro- and nanosuspensions, according to both solid-state and in vitro release profiles analysis. This work provides proof of concept for establishing a cost-effective experimental platform for the continuous production of injectable micro-and nanosuspensions of ITZ.

Preparation of Itraconazole Nanoparticles by Anti-Solvent Precipitation Method Using a Cascaded Microfluidic Device and an Ultrasonic Spray Drier

Continuous Preparation of Itraconazole Nanoparticles Using Droplet-Based Microreactor

Stable Single Device Multi-Pore Electrospraying of Polymeric Microparticles Via Controlled Electrostatic Interactions

Preparation of Smectic Itraconazole Nanoparticles with Tunable Periodic Order Using Microfluidics-Based Anti-Solvent Precipitation

Converting nanosuspension into inhalable and redispersible nanoparticles by combined in-situ thermal gelation and spray drying

Integrating micromixer precipitation and electrospray drying toward continuous production of drug nanoparticles

Controlled preparation of drug nanoparticles by integration of micromixer and electrospray

Supercritical enhanced atomization induced particle entrapment for continuous production of injectable micro and nano-suspensions

The Increased Dissolution and Oral Absorption of Itraconazole by Nanocrystals with an Endogenous Small-Molecule Surfactant as a Stabilizer

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Early development drug formulation on a chip: fabrication of nanoparticles using a microfluidic spray dryer

Mesoporous silica nanospheres as nanocarriers for poorly soluble drug itraconazole with high loading capacity and enhanced bioavailability

Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.

Bottom-up production of injectable itraconazole suspensions using membrane technology

Improve Solubility and Develop Personalized Itraconazole Dosages via Forming Amorphous Solid Dispersions with Hydrophilic Polymers Utilizing HME and 3D Printing Technologies

Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations

3D-printed microfluidics under ultrasonic cooling crystallization for nano-precipitation of Ezetimibe: Effect of process parameters and PBD approach

Electrospraying as a Means of Loading Itraconazole into Mesoporous Silica for Enhanced Dissolution

Design and preparation of nanostructures based on Krafft point of nonionic amphiphiles for delivery of poorly water-soluble compounds

Microfluidic Preparation of Nanoparticles Using Poly(ethylene Glycol)-distearoylphosphatidylethanolamine for Solubilizing Poorly Soluble Drugs

Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.